Insufficient scRNA-seq data for expression of NANOS1 at single-cell level.
Insufficient scRNA-seq data for expression of NANOS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 352.20 | 2615 / 2642 | 86% | 5.40 | 609 / 705 |
thymus | 99% | 479.00 | 648 / 653 | 85% | 13.05 | 516 / 605 |
adrenal gland | 100% | 821.46 | 258 / 258 | 79% | 7.71 | 182 / 230 |
breast | 95% | 714.27 | 436 / 459 | 73% | 6.46 | 813 / 1118 |
skin | 65% | 133.90 | 1182 / 1809 | 80% | 16.88 | 378 / 472 |
esophagus | 79% | 349.60 | 1135 / 1445 | 37% | 1.85 | 67 / 183 |
uterus | 65% | 146.09 | 111 / 170 | 49% | 2.99 | 223 / 459 |
lung | 62% | 100.67 | 356 / 578 | 45% | 2.06 | 519 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 49.32 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.36 | 1 / 1 |
muscle | 100% | 1224.63 | 799 / 803 | 0% | 0 | 0 / 0 |
adipose | 95% | 695.67 | 1146 / 1204 | 0% | 0 | 0 / 0 |
bladder | 76% | 353.24 | 16 / 21 | 14% | 0.81 | 73 / 504 |
heart | 85% | 340.45 | 736 / 861 | 0% | 0 | 0 / 0 |
pancreas | 51% | 64.20 | 166 / 328 | 33% | 1.91 | 59 / 178 |
ovary | 9% | 10.69 | 17 / 180 | 68% | 4.65 | 294 / 430 |
intestine | 70% | 183.77 | 675 / 966 | 6% | 0.24 | 33 / 527 |
stomach | 59% | 310.53 | 213 / 359 | 15% | 0.59 | 42 / 286 |
prostate | 56% | 78.76 | 136 / 245 | 7% | 0.26 | 36 / 502 |
kidney | 36% | 81.38 | 32 / 89 | 20% | 0.73 | 177 / 901 |
blood vessel | 48% | 139.94 | 644 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 42% | 1.59 | 19 / 45 |
lymph node | 0% | 0 | 0 / 0 | 38% | 2.49 | 11 / 29 |
liver | 1% | 0.70 | 2 / 226 | 18% | 1.02 | 74 / 406 |
peripheral blood | 9% | 8.59 | 79 / 929 | 0% | 0 | 0 / 0 |
spleen | 5% | 6.48 | 12 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0098749 | Biological process | cerebellar neuron development |
GO_0001894 | Biological process | tissue homeostasis |
GO_0061157 | Biological process | mRNA destabilization |
GO_0010608 | Biological process | post-transcriptional regulation of gene expression |
GO_0001558 | Biological process | regulation of cell growth |
GO_0048477 | Biological process | oogenesis |
GO_0016477 | Biological process | cell migration |
GO_0017148 | Biological process | negative regulation of translation |
GO_0010631 | Biological process | epithelial cell migration |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0030371 | Molecular function | translation repressor activity |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | NANOS1 |
Protein name | Nanos homolog 1 (NOS-1) (EC_Rep1a) Nanos homolog 1 |
Synonyms | NOS1 |
Description | FUNCTION: May act as a translational repressor which regulates translation of specific mRNAs by forming a complex with PUM2 that associates with the 3'-UTR of mRNA targets. Capable of interfering with the proadhesive and anti-invasive functions of E-cadherin. Up-regulates the production of MMP14 to promote tumor cell invasion. . |
Accessions | ENST00000340087.5 ENST00000425699.3 Q5T9H5 Q8WY41 |